Skip to Content
Merck
CN
  • Oral Administration of a Seed-based Bivalent Rotavirus Vaccine Containing VP6 and NSP4 Induces Specific Immune Responses in Mice.

Oral Administration of a Seed-based Bivalent Rotavirus Vaccine Containing VP6 and NSP4 Induces Specific Immune Responses in Mice.

Frontiers in plant science (2017-06-18)
Hao Feng, Xin Li, Weibin Song, Mei Duan, Hong Chen, Tao Wang, Jiangli Dong
ABSTRACT

Rotavirus is the leading cause of severe diarrheal disease among newborns. Plant-based rotavirus vaccines have been developed in recent years and have been proven to be effective in animal models. In the present study, we report a bivalent vaccine candidate expressing rotavirus subunits VP6 and NSP4 fused with the adjuvant subunit B of

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Mouse IgA (α-chain specific)−Peroxidase antibody produced in goat, affinity isolated antibody, buffered aqueous solution